← Home / REGENXBIO Inc. (RGNX)
Stock Analysis
REGENXBIO Inc. (RGNX)
RGNX
RGNX · Market data
9.69 -4.25%
Track RGNX in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when RGNX price is:
52W Range Position
39%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-02 14:47 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 9.86. Holding above 9.46 keeps the current thesis intact.
⚖️
✓
Fundamentals
Weak / Negative
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
9.46
↗
Break Above
Confirmation improves above resistance.
9.86
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 9.46
Recent Company Events
SEC VERIFIED
Latest material filings
JUN
29
●
Material Agreement
MEDIUM
RGNX material agreement
(the “Company”) announced that it has earned a milestone payment of $100.0 million from AbbVie Global Enterprises Ltd.
8-K Filing • SEC EDGAR
MAY
14
●
Financial Results
HIGH
REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights
• Company announced positive topline results from pivotal Phase III AFFINITY DUCHENNE ® study of RGX-202 o Primary endpoint achieved with high statistical significance o Statistically significant correlation between RGX-202 microdystrophin expression and functional improvement (NSAA, n=9), supporting validity of sur...
8-K Filing • SEC EDGAR
What's Driving RGNX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 9.86 for confirmation and 9.46 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 9.46
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
15.83
RSI(14)
42.8
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 6.73 and resistance at 9.86. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control.
Price Chart
RGNX — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$500.2M
Company size
EV
$490.8M
Debt-adjusted value
P/E
-1.7
Not meaningful
P/S
5.7
Balanced
P/B
23.7
Very high
EV/Sales
5.6
Balanced
EV/EBIT
-1.9
Not meaningful
P/FCF
-4.0
Not meaningful
FCF Yield
-25.31%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Pressured
💵 Revenue
6.39M
↘ Weak
📈 Net Income
-90.05M
↘ Negative
🧮 EPS (Basic)
-1.72
↘ Negative
REGENXBIO Inc.
Related Opportunities